FREQUENCY SELECTIVE MONITORING OF PHYSIOLOGICAL SIGNALS

• US 20090082691A1
• Filed: 09/25/2008
• Published: 03/26/2009
• Est. Priority Date: 09/26/2007
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Denison, Timothy J., Santa, Wesley A., Jensen, Randy M.
• Application Number:
  US12/237,868
• Publication Number:
  US 20090082691A1
• Time in Patent Office: Days
• US Class Current: 600/544
• CPC Class Codes: A61B 5/30 Input circuits therefor
• CPC Class Codes: A61B 5/305 Common mode rejection
• CPC Class Codes: A61B 5/31 for electroencephalography [EEG]
• CPC Class Codes: A61B 5/316 Modalities, i.e. specific diagnostic methods
• CPC Class Codes: A61B 5/374 Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
• CPC Class Codes: A61B 5/4082 Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
• CPC Class Codes: A61B 5/4094 Diagnosing or monitoring seizure diseases, e.g. epilepsy

Abstract

In general, the disclosure is directed to a frequency selective monitor and methods for monitoring physiological signals in one or more selected frequency bands. A frequency selective monitor may utilize a heterodyning, chopper-stabilized amplifier architecture to convert a selected frequency band to a baseband for analysis. The frequency selective monitor may be useful in a variety of therapeutic and/or diagnostic applications. As examples, a frequency selective signal monitor may be provided within a medical device or within a sensor coupled to a medical device. The physiological signal may be analyzed in one or more selected frequency bands to trigger delivery of patient therapy and/or recording of diagnostic information.

Claims

1. A physiological signal monitoring device comprising:

a physiological sensing element that receives a physiological signal;

a heterodyning circuit configured to convert a selected frequency band of the physiological signal to a baseband; and

a signal analysis unit that analyzes a characteristic of the signal in the selected frequency band.

2. The device of claim 1, wherein the heterodyning circuit comprises:

a modulator that modulates the signal at a first frequency;

an amplifier that amplifies the modulated signal; and

a demodulator that demodulates the amplified signal at a second frequency different from the first frequency, wherein the second frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the baseband.

3. The device of claim 2, wherein the second frequency differs from the first frequency by an offset that is approximately equal to a center frequency of the selected frequency band.

4. The device of claim 1, wherein the signal analysis unit comprises a lowpass filter that filters the converted signal to extract the selected frequency band of the signal at the baseband.

5. The device of claim 1, wherein the physiological signal is brain signal and the selected frequency band is one of an alpha, beta, gamma or fast ripple frequency band of the brain signal.

6. The device of claim 5, wherein the brain signal comprises at least one of an electroencephalogram (EEG) signal, an electrocorticogram (ECOG) signal, a local field potential (LFP) signal, or a single cell action potential signal.

7. The device of claim 1, wherein the characteristic of the signal is a power fluctuation of the signal in the selected frequency band, and wherein the signal analysis unit generates a signal triggering at least one of control of therapy to the patient or recording of diagnostic information when the power fluctuation exceeds a threshold.

8. The device of claim 1, wherein the selected frequency band comprises a first selected frequency band and the characteristic comprises a first power, wherein the heterodyning circuit is further configured to convert a second selected frequency band of the signal to the baseband, and wherein the signal analysis unit analyzes a second power of the signal in the second selected frequency band, and calculates a power ratio between the first power and the second power.

9. The device of claim 8, wherein the signal analysis unit generates a signal triggering at least one of control of therapy to the patient or recording of diagnostic information based on the power ratio.

10. The device of claim 1, wherein the heterodyning circuit comprises:

a first modulator that modulates the signal at a first frequency to produce a first modulated signal;

a second modulator that modulates the first modulated signal at a second frequency different from the first frequency to produce a second modulated signal;

an amplifier that amplifies the second modulated signal;

a first demodulator that demodulates the amplified signal at a third frequency different from the second frequency, wherein the third frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the first frequency; and

a second demodulator that demodulates the demodulated signal at the first frequency such that the selected frequency band is substantially centered at the baseband.

11. The device of claim 10, wherein the heterodyning circuit further comprises a second amplifier that amplifies the demodulated signal to produce a second amplified signal, and wherein the second demodulator demodulates the second amplified signal at the first frequency.

12. The device of claim 10, wherein the first frequency is less than the second frequency.

13. A method for monitoring a physiological signal, the method comprising:

receiving a physiological signal;

converting, with a heterodyning circuit, a selected frequency band of the physiological signal to a baseband; and

analyzing a characteristic of the signal in the selected frequency band.

14. The method of claim 13, wherein converting, with the heterodyning circuit, the selected frequency band of the physiological signal to the baseband comprises:

modulating the signal at a first frequency;

amplifying the modulated signal; and

demodulating the amplified signal at a second frequency different from the first frequency, wherein the second frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the baseband.

15. The method of claim 14, wherein the second frequency differs from the first frequency by an offset that is approximately equal to a center frequency of the selected frequency band.

16. The method of claim 13, further comprising lowpass filtering the converted signal to extract the selected frequency band of the signal at the baseband.

17. The method of claim 13, wherein the physiological signal is brain signal and the selected frequency band is one of an alpha, beta, gamma or fast ripple frequency band of the brain signal.

18. The method of claim 17, wherein the brain signal comprises at least one of an electroencephalogram (EEG) signal, an electrocorticogram (ECOG) signal, a local field potential (LFP) signal, or a single cell action potential signal.

19. The method of claim 13, wherein the characteristic of the signal is a power fluctuation of the signal in the selected frequency band, the method further comprising generating a signal triggering at least one of control of therapy to the patient or recording of diagnostic information when the power fluctuation exceeds a threshold.

20. The method of claim 13, wherein the selected frequency band comprises a first selected frequency band and the characteristic comprises a first power, the method further comprising:

converting, with the heterodyning circuit, a second selected frequency band of the signal to the baseband;

analyzing a second power of the signal in the second selected frequency band; and

calculating a power ratio between the first power and the second power.

21. The method of claim 20, further comprising generating a signal triggering at least one of control of therapy to the patient or recording of diagnostic information based on the power ratio.

22. The method of claim 13, wherein converting, with the heterodyning circuit, the selected frequency band of the physiological signal to the baseband comprises:

modulating the signal at a first frequency to produce a first modulated signal;

modulating the first modulated signal at a second frequency different from the first frequency to produce a second modulated signal;

amplifying the second modulated signal;

demodulating the amplified signal at a third frequency different from the second frequency, wherein the third frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the first frequency; and

demodulating the demodulated signal at the first frequency such that the selected frequency band is substantially centered at the baseband.

23. The method of claim 22, further comprising amplifying the demodulated signal to produce a second amplified signal, and wherein demodulating the demodulated signal at the first frequency comprises demodulating the second amplified signal at the first frequency.

24. The method of claim 22, wherein the first frequency is less than the second frequency.

25. A physiological signal monitoring device comprising:

means for receiving a physiological signal;

means for converting, with a heterodyning circuit, a selected frequency band of the physiological signal to a baseband; and

means for analyzing a characteristic of the signal in the selected frequency band.

26. The device of claim 25, wherein the means for converting, with the heterodyning circuit, the selected frequency band of the physiological signal to the baseband comprises:

means for modulating the signal at a first frequency;

means for amplifying the modulated signal; and

means for demodulating the amplified signal at a second frequency different from the first frequency, wherein the second frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the baseband.

27. The device of claim 26, wherein the second frequency differs from the first frequency by an offset that is approximately equal to a center frequency of the selected frequency band.

28. The device of claim 25, further comprising means for lowpass filtering the converted signal to extract the selected frequency band of the signal at the baseband.

29. The device of claim 25, wherein the physiological signal is brain signal and the selected frequency band is one of an alpha, beta, gamma or fast ripple frequency band of the brain signal.

30. The device of claim 29, wherein the brain signal comprises at least one of an electroencephalogram (EEG) signal, an electrocorticogram (ECOG) signal, a local field potential (LFP) signal, or a single cell action potential signal.

31. The device of claim 25, wherein the characteristic of the signal is a power fluctuation of the signal in the selected frequency band, the device further comprising means for generating a signal triggering at least one of control of therapy to the patient or recording of diagnostic information when the power fluctuation exceeds a threshold.

32. The device of claim 25, wherein the selected frequency band comprises a first selected frequency band and the characteristic comprises a first power, the device further comprising:

means for converting, with the heterodyning circuit, a second selected frequency band of the signal to the baseband;

means for analyzing a second power of the signal in the second selected frequency band; and

means for calculating a power ratio between the first power and the second power.

33. The device of claim 32, further comprising means for generating a signal triggering at least one of control of therapy to the patient or recording of diagnostic information based on the power ratio.

34. The device of claim 25, wherein the means for converting, with the heterodyning circuit, the selected frequency band of the physiological signal to the baseband comprises:

means for modulating the signal at a first frequency to produce a first modulated signal;

means for modulating the first modulated signal at a second frequency different from the first frequency to produce a second modulated signal;

means for amplifying the second modulated signal;

means for demodulating the amplified signal at a third frequency different from the second frequency, wherein the third frequency is selected such that the demodulator substantially centers the selected frequency band of the signal at the first frequency; and

means for demodulating the demodulated signal at the first frequency such that the selected frequency band is substantially centered at the baseband.

35. The device of claim 34, further comprising means for amplifying the demodulated signal to produce a second amplified signal, and wherein the means for demodulating the demodulated signal at the first frequency comprises means for demodulating the second amplified signal at the first frequency.

36. The device of claim 34, wherein the first frequency is less than the second frequency.

37. A medical device comprising:

a physiological signal monitoring unit comprising;

a physiological sensing element that receives a physiological signal,

a heterodyning circuit configured to covert a selected frequency band of the physiological signal to a baseband, and

a signal analysis unit that analyzes a characteristic of the signal in the selected frequency band, and generates a trigger signal triggering control of therapy to the patient based on the analyzed characteristic; and

a therapy delivery module that controls the therapy in response to the trigger signal.

38. The device of claim 37, wherein the heterodyning circuit comprises:

a modulator that modulates the signal at a first frequency;

an amplifier that amplifies the modulated signal; and

a demodulator that demodulates the amplified signal at a second frequency different from the first frequency, wherein the second frequency is selected such that the demodulator substantially centers a selected frequency band of the signal at the baseband.

39. The device of claim 38, wherein the second frequency differs from the first frequency by an offset that is approximately equal to a center frequency of the selected frequency band, and the physiological signal is brain signal and the selected frequency band is one of an alpha, beta, gamma or fast ripple frequency band of the brain signal.

40. The device of claim 37, wherein the control of the therapy comprises at least one of initiating delivery of the therapy or adjusting one or more parameters of the therapy.

41. The device of claim 37, wherein frequencies in the selected frequency band are less or equal than approximately 500 Hz.